Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

First-year B Pharm student commits suicide in Bhopal

Ruchika Sharma31 Aug 2022 5:00 PM IST

The initial probe revealed that the man had wrapped the wires around his hands and switched on the power supply, the official said.

Medical device maker Philips expands respiratory devices recall over possible plastic contamination

Ruchika Sharma31 Aug 2022 4:30 PM IST

"All affected devices with the non-conforming plastic will therefore be remediated in the June 2021 field action," the company said.

Himachal Pradesh: CM Jai Ram Thakur thanks PM Modi for allocation of Rs 1200 crore Bulk Drug Pharma Park to state

Ruchika Sharma31 Aug 2022 3:39 PM IST

Chief Minister Jai Ram Thakur said that the prime objectives of allocating bulk drug pharma park to Himachal Pradesh and other states are augmenting...

SII, Department of Biotechnology to launch India's first qHPV vaccine against cervical cancer tomorrow

Ruchika Sharma31 Aug 2022 2:52 PM IST

"It is very effective and prevents cervical cancer because, 85 percent to 90 percent cases, cervical cancer is because of this particular virus and...

Glenmark Specialty, Hikma Pharma launch seasonal allergic rhinitis nasal spray RYALTRIS in US

Ruchika Sharma31 Aug 2022 1:30 PM IST

The onset of action for nasal symptom relief occurs within 15 minutes of a patient taking the first dose.

Zydus Lifecsciences begins Desidustat Phase IV trial in patients with CKD induced anemia

Ruchika Sharma31 Aug 2022 12:30 PM IST

Desidustat is currently approved in India as Oxemia for the treatment of anemia in Chronic Kidney Disease (CKD) patients.

Granules India Diarrhea medicine gets USFDA okay

Ruchika Sharma31 Aug 2022 11:00 AM IST

Loperamide Hydrochloride and Simethicone Tablets are indicated to relieve symptoms of diarrhea plus bloating, pressure and cramps, commonly referred...

AstraZeneca Tagrisso gets Japanese okay for early-stage EGFR-mutated lung cancer

Ruchika Sharma30 Aug 2022 9:45 AM IST

New Delhi: AstraZeneca's Tagrisso (osimertinib) has been approved in Japan for the adjuvant treatment of patients with epidermal growth factor...

Low-Risk Medical Device Makers Get Clarity: CDSCO Publishes Class A Risk Classification List under MDR 2017

PLI Scheme for medical devices: DoP invites applications from Category B applicants under revised guidelines

Ruchika Sharma29 Aug 2022 6:00 PM IST

New Delhi: In order to boost the production of medical devices in the country, through a recent notification, the Department of Pharmaceuticals(DoP),...

Healthcare focused SaaS startup Zealthix raises USD 1.1 million in seed round

Siam Bioscience reports record profit after COVID vaccine deal with AstraZeneca

Ruchika Sharma29 Aug 2022 10:45 AM IST

Bangkok: Thai drugmaker Siam Bioscience, owned by the country's king, reported a near 50-fold increase in annual profit in 2021, when it began...

AstraZeneca gets Japenese nod for Ultomiris to treat generalised myasthenia gravis

Ruchika Sharma29 Aug 2022 9:30 AM IST

gMG is a rare, debilitating, chronic, autoimmune neuromuscular disease that leads to a loss of muscle function and severe weakness.

Janssen bags USFDA nod for IMBRUVICA for chronic graft-versus-host disease treatment

Ruchika Sharma28 Aug 2022 12:45 PM IST

Chronic graft-versus-host disease is a life-threatening complication that can occur after a stem cell or bone marrow transplant when newly...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok